A study showed that knockdown of SNHG5 remarkably inhibited GSK3β and the Wnt/β-catenin pathway in hepatocellular carcinoma (HCC) or brain glioma cell lines [38, 48]. Here, SNHG5 is linked to hepatocellular carcinoma.